new_0222_0453|VERA|Short Name|0|0|total_current_assets|cash_on_hand|inventories_net|net_ppe|goodwill_and_intangible|liabilities|total_current_liabilities|total_long_term_liab|total_deposits|book_value_of_equity|retained_earnings|treasury_stock|ev_revenues|ev_earnings|ev_free_cash_flow|ev_assets|ps_ratio|pe_ratio|price_to_book_value|peg_ratio|debt_equity_ratio|dividend_yield|shareholder_yield_ttm|percent_of_shares_outstanding|receivables|payables|capital_stock|return_on_invested_capital|quality_ratio_fractile|momentum_fractile|market_beta_12_month|sustainable_growth_rate|institutional_investor_ownership_percentage|average_shares_outs_diluted|total_employee_number|eps|shares_outstanding|repurchase_of_capital_stock|ordinary_shares_number|payout_ratio|quick_ratio|normalized_eps|stock_buyback|effective_tax_rate|return_on_equity|net_income_ttm|revenues_ttm|dividend_per_share|revenues|gross_profit|sga_expense|pre_tax_income|net_income|interest_income|price|total_return_price|enterprise_value|average_volume_30|one_year_return
new_0222_0453|VERA|Long Name|1|1|Vera Therapeutics Inc Total Current Assets (Quarterly) (USD)|Vera Therapeutics Inc Cash and Short Term Investments (Quarterly) (USD)|Vera Therapeutics Inc Inventories (Quarterly) (USD)|Vera Therapeutics Inc Net PP&E (Quarterly) (USD)|Vera Therapeutics Inc Goodwill and Intangibles (Quarterly) (USD)|Vera Therapeutics Inc Total Liabilities (Quarterly) (USD)|Vera Therapeutics Inc Total Current Liabilities (Quarterly) (USD)|Vera Therapeutics Inc Total Long Term Liabilities (Quarterly) (USD)|Vera Therapeutics Inc Total Deposits (Quarterly) (USD)|Vera Therapeutics Inc Book Value (Quarterly) (USD)|Vera Therapeutics Inc Retained Earnings (Quarterly) (USD)|Vera Therapeutics Inc Treasury Stock (Quarterly) (USD)|Vera Therapeutics Inc EV to Revenues|Vera Therapeutics Inc EV to Earnings|Vera Therapeutics Inc EV to Free Cash Flow|Vera Therapeutics Inc EV to Assets (Quarterly)|Vera Therapeutics Inc PS Ratio|Vera Therapeutics Inc PE Ratio|Vera Therapeutics Inc Price to Book Value|Vera Therapeutics Inc PEG Ratio|Vera Therapeutics Inc Debt to Equity Ratio|Vera Therapeutics Inc Dividend Yield|Vera Therapeutics Inc Shareholder Yield (TTM)|Vera Therapeutics Inc Percent of Shares Outstanding Short|Vera Therapeutics Inc Total Receivables (Quarterly) (USD)|Vera Therapeutics Inc Total Payables (Quarterly) (USD)|Vera Therapeutics Inc Total Capital Stock (Quarterly) (USD)|Vera Therapeutics Inc Return on Invested Capital|Vera Therapeutics Inc Quality Ratio Score|Vera Therapeutics Inc Momentum Score|Vera Therapeutics Inc Beta (1Y)|Vera Therapeutics Inc Sustainable Growth Rate (TTM)|Vera Therapeutics Inc Institutional Investor Ownership Percentage|Vera Therapeutics Inc Average Diluted Shares Outstanding (Quarterly)|Vera Therapeutics Inc Total Employees (Annual)|Vera Therapeutics Inc EPS Diluted (Quarterly) (USD)|Vera Therapeutics Inc Shares Outstanding|Vera Therapeutics Inc Repurchase of Capital Stock (Quarterly) (USD)|Vera Therapeutics Inc Ordinary Shares Number (Quarterly)|Vera Therapeutics Inc Payout Ratio|Vera Therapeutics Inc Quick Ratio (Quarterly)|Vera Therapeutics Inc Normalized Diluted EPS (Quarterly) (USD)|Vera Therapeutics Inc Stock Buybacks (Quarterly) (USD)|Vera Therapeutics Inc Effective Tax Rate (TTM)|Vera Therapeutics Inc Return on Equity|Vera Therapeutics Inc Net Income (TTM) (USD)|Vera Therapeutics Inc Revenue (TTM) (USD)|Vera Therapeutics Inc Dividend Per Share (Quarterly) (USD)|Vera Therapeutics Inc Revenue (Quarterly) (USD)|Vera Therapeutics Inc Gross Profit (Quarterly) (USD)|Vera Therapeutics Inc SG&A Expense (Quarterly) (USD)|Vera Therapeutics Inc Pre-Tax Income (Quarterly) (USD)|Vera Therapeutics Inc Net Income (Quarterly) (USD)|Vera Therapeutics Inc Net Interest Income (Quarterly) (USD)|Vera Therapeutics Inc Price (USD)|Vera Therapeutics Inc Total Return Price (USD)|Vera Therapeutics Inc Enterprise Value (USD)|Vera Therapeutics Inc 30-Day Average Daily Volume|Vera Therapeutics Inc 1 Year Price Returns (Daily)
new_0222_0453|VERA|Unit|2|2|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|percent_USD_metric|percent_USD_metric|percent_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|percent_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_beta|percent_USD_metric|percent_USD_metric|mil_figure_USD_metric|figure_whole_USD_metric|figure_money_USD_per_share_metric|mil_figure_USD_metric|mil_figure_money_USD_metric|mil_figure_USD_metric|percent_USD_metric|figure_USD_metric|figure_money_USD_per_share_metric|mil_figure_money_USD_metric|percent_USD_metric|percent_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|figure_money_USD_per_share_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|figure_money_USD_price|figure_money_USD_price|mil_figure_money_USD_metric|figure_USD_metric|percent_USD_metric
new_0222_0453|VERA||4|4|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|daily|quarterly|quarterly|quarterly|daily|quarterly|quarterly|daily|quarterly|monthly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|monthly|quarterly|quarterly|quarterly|monthly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|daily|daily|daily|daily|quarterly
new_0222_0453|VERA||5|5|91|91|0|0|0|91|91|91|0|91|91|0|0|0|1.44559585492|0|0|0|1.43827160494|0|0|1.44559585492|0|15.4117647059|91|91|91|0|0|0|0|0|30.625|91.3333333333|91|91.3333333333|22.125|0|91|0|0|91.3333333333|91.4|0|0|91|0|0|0|0|91.3333333333|91.3333333333|91.3333333333|91.3333333333|1.44329896907|1.44329896907|1.44559585492|1.44512195122|0
new_0222_0453|VERA||6|6|3|3|0|0|0|3|3|3|0|3|3|0|0|0|193|0|0|0|162|0|0|193|0|17|3|3|3|0|0|0|0|0|8|6|3|6|8|0|3|0|0|6|5|0|0|3|0|0|0|0|6|6|6|6|194|194|193|164|0
new_0222_0453|VERA||7|7|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|daily|quarterly|daily|quarterly|daily|daily|daily|daily|quarterly|daily|quarterly|daily|quarterly|quarterly|quarterly|quarterly|quarterly|monthly|monthly|quarterly|monthly|quarterly|yearly|quarterly|daily|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|market_daily|market_daily|daily|market_daily|market_daily
new_0222_0453|VERA|202003|202003|202003||||||||||||||||||||||||||||||||||4.0763||-0.6069||||||-0.6069|||||||||1.032|-2.474|-2.474|0.044|||||
new_0222_0453|VERA|202006|202006|202006||||||||||||||||||||||||||||||||||4.0763||-0.8841||||||-0.8841|0||||||||1.219|-3.604|-3.604|-0.062|||||
new_0222_0453|VERA|202009|202009|202009||||||||||||||||||||||||||||||||||4.0763||-1.0941||||||-0.7467|0||||||||0.652|-4.46|-4.46|-0.064|||||
new_0222_0453|VERA|202012|202012|202012|54.261|53.654||0||143.902|2.406|141.496||-89.348|-91.447||||||||||||||0.052|0.909|0|||||||4.0763|29|-10.518|||20.4793|||-10.1304||||-53.413|||||1.136|-42.874|-42.875|-0.013|||||
new_0222_0453|VERA|202103|202103|202103|51.532|49.505||||145.141|3.753|141.388||-93.316|-96.161||||||||||||||0|1.739|0|||||||20.4793|12|-0.2302|||20.4793|||-0.2302||||-55.653|||||1.784|-4.714|-4.714|0.002|||||
new_0222_0453|VERA|202105|202103|202103|||||||||||||||-8.6012|||||||0||0.0366|||||||||53.0334||||21.1318||||||||||||||||||17.25|17.25|315.0186||
new_0222_0453|VERA|202106|202106|202106|95.876|91.625||||5.492|3.771|1.721||92.155|-99.598||||-4.5781||||3.0616|||0||0.0331|0|2.44|0.021||||||86.8433|10.4999|13|-0.33|21.2776||21.2776|||-0.5595|-51.176|||-55.486|||||2.614|-3.437|-3.437|0.002|13.26|13.26|190.516|59493.6667|
new_0222_0453|VERA|202107|202106|202106|||||||||||||||-7.0016||||4.156|||0||0.0477|||||||||86.4725||||||||||||||||||||||18|18|291.3718|15541.6667|
new_0222_0453|VERA|202108|202106|202106|||||||||||||||-5.3348||||3.4033|||0||0.0147|||||||||86.9772||||21.2776||||||||||||||||||14.74|14.74|222.0068|11967.3|
new_0222_0453|VERA|202109|202109|202109|89.76|86.191||||5.69|4.042|1.648||85.477|-107.209||||-6.3374||||4.3189|||0||0.5221|0|1.958|0.021||||||96.203|21.2655|9|-0.36|21.2776||21.2776|||-0.3429|0|||-58.637|||||3.688|-7.611|-7.611|0.005|17.35|17.35|282.9754|117415.3667|
new_0222_0453|VERA|202110|202109|202109|||||||||||||||-7.2904||||4.8168|||0||0.8701|||||||||96.0508||||||||||||||||||||||19.35|19.35|325.5306|65189|
new_0222_0453|VERA|202111|202109|202109|||||||||||||||-15.1292||||8.9116|||0||0.3729|||||||||96.5712||||21.2776||||||||||||||||||35.8|35.8|675.5471|38268.6667|
new_0222_0453|VERA|202112|202112|202112|||||||||||||||-10.8023||||6.6514|||0||1.1405|||||||||98.1233||||||||||||||||||||||26.72|26.72|482.3465|81156.6333|
new_0222_0453|VERA|202201|202112|202112|||||||||||||||-7.5668||||4.9611|||0||1.6863|||||||||98.0946||||||||||||||||||||||19.93|19.93|337.8716|79796.9|
new_0222_0453|VERA|202202|202112|202112|||||||||||||||-8.0719||||5.5884|||0|||||||||||||||||||||||||||||||||22.45|22.45|360.4258|116563.9333|